Immuneering Corporation (IMRX)

Import this data to Google Sheets with:

=jivedata("IMRX","financials")

Full statements spill as a table. For one cell: =jivedata("IMRX","Revenue") or =jivedata("IMRX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Immuneering Corporation

IMRX • CIK 0001790340

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Research and Development Expense	$41,624.018	$47,964.388	$42,048.461	$44,764.478
General and Administrative Expense	$16,759.602	$16,077.746	$17,298.241	$18,675.121
Operating Income (Loss)	$-58,412.887	$-64,071.401	$-59,375.969	$-63,468.866
Amortization of Intangible Assets	$29.267	$29.267	$29.267	$29.267
Operating Expenses	$58,412.887	$64,071.401	$59,375.969	$63,468.866
Net Income (Loss) Attributable to Parent	$-53,471.622	$-61,036.608	$-56,024.898	$-57,276.208
Weighted Average Number of Shares Outstanding, Basic	28,416,558	29,981,565	44,011,830	72,930,924
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-53,442.28	$-61,035.83	$-55,943.566	$-57,682.448
Investment Income, Interest	$3,606.996	$2,593.3	$3,039.406	$4,720.062
Other Nonoperating Income (Expense)	$1,334.269	$441.493	$311.665	$1,472.596
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax	$29.342	$0.778	$81.332	$-406.24

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent	—	—	$44,183.186	$32,773.479
Property, Plant and Equipment, Net	$1,400.582	$1,122.865	$938.481	$879.922
Goodwill	$6,690.431	$6,690.431	$6,690.431	$6,690.431
Finite-Lived Intangible Assets, Net	$379.68	$350.413	$321.147	$306.513
Operating Lease, Right-of-Use Asset	$3,995.73	$3,667.352	$3,322.249	$3,136.353
Other Assets, Noncurrent	$1,034.446	$1,295.783	$283.562	$278.124
Assets	$102,584.538	$52,714.413	$231,985.01	$202,055.327
Liabilities	$12,008.355	$11,328.187	$13,501.042	$11,320.301
Cash and Cash Equivalents, at Carrying Value	$59,405.817	$36,144.72	$128,645.025	$41,324.682
DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	—	—	$44,186.244	$108,575.637
Prepaid Expense and Other Assets, Current	$3,417.984	$3,442.849	$3,414.685	$8,090.186
Assets, Current	$89,083.669	$39,587.569	$176,245.954	$157,990.505
Accounts Payable, Current	$2,111.666	$1,958.536	$1,542.737	$3,377.359
Accrued Liabilities, Current	$5,173.96	$4,973.129	$7,842.367	$4,094.874
Other Liabilities, Current	$259.77	$233.665	$291.513	$214.461
Operating Lease, Liability, Current	$300.107	$338.438	$397.104	$428.962
Liabilities, Current	$7,845.503	$7,503.768	$10,073.721	$8,115.656
Operating Lease, Liability, Noncurrent	$4,162.852	$3,824.419	$3,427.321	$3,204.645
Preferred Stock, Value, Issued	$0	$0	$0	$0
Additional Paid in Capital	$253,806.267	$265,650.362	$498,658.072	$502,127.975
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-0.778	$0	$81.332	$-406.24
Retained Earnings (Accumulated Deficit)	$-163,258.578	$-224,295.186	$-280,320.084	$-311,051.406
Stockholders' Equity Attributable to Parent	$90,576.183	$41,386.226	$218,483.968	$190,735.026
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0	0	0

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-13,231.069	$-23,261.097	$92,500.305	$14,969.184
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$59,405.817	$36,144.72	$128,645.025	$140,100.895
Net Income (Loss) Attributable to Parent	$-53,471.622	$-61,036.608	$-56,024.898	$-57,276.208
Net Cash Provided by (Used in) Operating Activities	$-48,968.634	$-54,999.571	$-45,344.595	$-56,752.67
Payments to Acquire Property, Plant, and Equipment	$342.746	$84.875	$142.226	$238.462
Payments to Acquire Marketable Securities	$44,660.762	$5,410.17	$88,596.021	$172,579.598
Proceeds from Sale and Maturity of Marketable Securities	$52,300	$31,930	$0	$31,500
Net Cash Provided by (Used in) Investing Activities	$7,296.492	$26,434.955	$-88,738.247	$-141,318.06
Payments of Stock Issuance Costs	$203.768	$40.988	$3,726.266	$3,662.253
Proceeds from Stock Options Exercised	$444.838	$732.458	$368.532	$401.52
Proceeds from Issuance of Common Stock	$28,200.003	—	—	—
Proceeds from Stock Plans	—	$374.652	$421.91	$458.343
Net Cash Provided by (Used in) Financing Activities	$28,441.073	$5,303.519	$226,583.147	$213,039.914
Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction	—	—	$45	$-19.015
Depreciation, Depletion and Amortization	—	$355.807	$324.517	$320.585
Operating Lease, Right-of-Use Asset, Amortization Expense	$412.055	$328.377	$345.103	$362.613
Amortization of Intangible Assets	$29.267	$29.267	$29.267	$29.267
Share-based Payment Arrangement, Noncash Expense	$5,727.135	$6,501.366	$6,311.135	$6,358.509
Accretion (Amortization) of Discounts and Premiums, Investments	$1,017.583	$259.181	$155.748	$1,139.43
Gain (Loss) on Disposition of Property Plant Equipment	$-3.939	$-6.784	$-2.093	$-2.093
Increase (Decrease) in Prepaid Expense and Other Assets	$172.66	$24.865	$-491.837	$6,256.585
Increase (Decrease) in Other Operating Assets	$290.742	$261.337	$-1,114.245	$-665.627
Increase (Decrease) in Accounts Payable	$-1,106.896	$-112.143	$-400.799	$933.144
Increase (Decrease) in Accrued Liabilities	$721.989	$-200.831	$2,899.237	$-390.086
IncreaseDecreaseInOperatingLeaseLiability	$-378.723	$-300.102	$-338.432	$-366.952
Increase (Decrease) in Other Operating Liabilities	$239.974	$-26.105	$57.848	$4.753

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("IMRX","financials")

Full statements spill as a table. For one cell: =jivedata("IMRX","Revenue") or =jivedata("IMRX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.